These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24354673)

  • 1. Natural & synthetically-modified cyclodextrins and polymers in drug delivery systems.
    Otero-Espinar FJ; Blanco-Méndez J
    Curr Top Med Chem; 2014; 14(4):463-4. PubMed ID: 24354673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin based rotaxanes, polyrotaxanes and polypseudorotaxanes and their biomedical applications.
    García-Río L; Otero-Espinar FJ; Luzardo-Alvarez A; Blanco-Méndez J
    Curr Top Med Chem; 2014; 14(4):478-93. PubMed ID: 24354671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications.
    van de Manakker F; Vermonden T; van Nostrum CF; Hennink WE
    Biomacromolecules; 2009 Dec; 10(12):3157-75. PubMed ID: 19921854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Cyclodextrins in Nanoparticle-Based Drug Delivery Systems.
    Shelley H; Babu RJ
    J Pharm Sci; 2018 Jul; 107(7):1741-1753. PubMed ID: 29625157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Carrier Systems Based on Cyclodextrin Supramolecular Assemblies and Polymers: Present and Perspectives.
    Gonzalez-Gaitano G; Isasi JR; Velaz I; Zornoza A
    Curr Pharm Des; 2017; 23(3):411-432. PubMed ID: 27855609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
    Lakkakula JR; Maçedo Krause RW
    Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interactions between cyclodextrins and triglycerides: from emulsion stabilisation to the emergence of a new drug delivery system called "beads"].
    Hamoudi M; Trichard L; Grossiord JL; Chaminade P; Duchêne D; Le Bas G; Fattal E; Bochot A
    Ann Pharm Fr; 2009 Nov; 67(6):391-8. PubMed ID: 19900602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin-based polysaccharidic polymers: an approach for the drug delivery.
    Luzardo-Alvarez A; Sobarzo-Sánchez E; Blanco-Méndez J; Otero-Espinar FJ
    Curr Top Med Chem; 2014; 14(4):542-51. PubMed ID: 24354666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications.
    Zafar N; Fessi H; Elaissari A
    Int J Pharm; 2014 Jan; 461(1-2):351-66. PubMed ID: 24342710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems.
    Bibby DC; Davies NM; Tucker IG
    Int J Pharm; 2000 Mar; 197(1-2):1-11. PubMed ID: 10704788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the role of supramolecular hydrogels in drug delivery.
    Amin MC; Ahmad N; Pandey M; Abeer MM; Mohamad N
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1149-61. PubMed ID: 25547588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin-based delivery systems for cancer treatment.
    Zhang D; Lv P; Zhou C; Zhao Y; Liao X; Yang B
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():872-886. PubMed ID: 30606602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphiphilic cyclodextrin nanoparticles.
    Varan G; Varan C; Erdoğar N; Hıncal AA; Bilensoy E
    Int J Pharm; 2017 Oct; 531(2):457-469. PubMed ID: 28596142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiphilic Cyclodextrin Derivatives for Targeted Drug Delivery to Tumors.
    Erdogar N; Varan G; Bilensoy E
    Curr Top Med Chem; 2017; 17(13):1521-1528. PubMed ID: 28017158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclodextrins Based Electrochemical Sensors for Biomedical and Pharmaceutical Analysis.
    Lenik J
    Curr Med Chem; 2017; 24(22):2359-2391. PubMed ID: 27978804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro.
    Hipler UC; Schönfelder U; Hipler C; Elsner P
    J Biomed Mater Res A; 2007 Oct; 83(1):70-9. PubMed ID: 17380497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrin-functionalized polymers as drug carriers for cancer therapy.
    Wei H; Yu CY
    Biomater Sci; 2015 Jul; 3(7):1050-60. PubMed ID: 26221939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring versatile applications of cyclodextrins: an overview.
    Sharma N; Baldi A
    Drug Deliv; 2016; 23(3):739-57. PubMed ID: 25051096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin-based pharmaceutics: past, present and future.
    Davis ME; Brewster ME
    Nat Rev Drug Discov; 2004 Dec; 3(12):1023-35. PubMed ID: 15573101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.
    Li J; Loh XJ
    Adv Drug Deliv Rev; 2008 Jun; 60(9):1000-17. PubMed ID: 18413280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.